Zoetis | ZTS - Operating Profit

Stock Price
126.73
Daily Change
4.32 3.53%
Monthly
-2.04%
Yearly
-27.86%
Q1 Forecast
120.98

Zoetis reported $936M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
AbbVie USD 5.81B 1.23B Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
Bayer EUR -543M 556M Sep/2025
Bristol-Myers Squibb USD 3.64B 135M Sep/2025
Charles River Laboratories USD 133.8M 1.46M Sep/2025
Dentsply International USD 512M 401M Sep/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Henry Schein USD 198M 22M Sep/2025
Idexx Laboratories USD 315.6M 39.24M Dec/2025
Illumina USD 250M 5M Sep/2025
IQVIA Holdings USD 573M 17M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Laboratory Of America USD 397.3M 65.5M Sep/2025
Merck USD 6.24B 318M Dec/2025
Neogen USD -5.38M 10.71M Sep/2025
Pacira USD 13.15M 2.92M Sep/2025
Perrigo USD 93.4M 37.8M Sep/2025
Pfizer USD 4.65B 3.99B Dec/2025
Quest Diagnostics USD 386M 52M Sep/2025
Sanofi EUR 1.7B 2.17B Dec/2025
Sanofi EUR 1.5B 2.29B Dec/2025
Zoetis USD 936M 63M Sep/2025